| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-12 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |